Coloplast A/S (CLPBY)
USD 10.98
(-0.27%)
USD 10.98
(-0.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.52 Billion DKK | 10.51% |
| 2022 | 3.18 Billion DKK | 31.26% |
| 2021 | 2.42 Billion DKK | 9.03% |
| 2020 | 2.22 Billion DKK | 15.21% |
| 2019 | 1.93 Billion DKK | 12.06% |
| 2018 | 1.72 Billion DKK | 1.95% |
| 2017 | 1.69 Billion DKK | 11.46% |
| 2016 | 1.51 Billion DKK | 3.05% |
| 2015 | 1.47 Billion DKK | 11.42% |
| 2014 | 1.32 Billion DKK | 23.67% |
| 2013 | 1.06 Billion DKK | 6.05% |
| 2012 | 1 Billion DKK | 6.55% |
| 2011 | 946 Million DKK | -1.36% |
| 2010 | 959 Million DKK | -2.74% |
| 2009 | 986 Million DKK | -19.44% |
| 2008 | 1.22 Billion DKK | 30.21% |
| 2007 | 940 Million DKK | 11.37% |
| 2006 | 844 Million DKK | 20.92% |
| 2005 | 698 Million DKK | -24.36% |
| 2004 | 922.75 Million DKK | 4.5% |
| 2003 | 883 Million DKK | 21.29% |
| 2002 | 728 Million DKK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.51 Billion DKK | -0.09% |
| 2024 Q2 | 3.56 Billion DKK | 1.22% |
| 2024 Q3 | 3.67 Billion DKK | 3.2% |
| 2023 Q2 | 3.51 Billion DKK | 3.39% |
| 2023 Q4 | 3.52 Billion DKK | -0.98% |
| 2023 Q1 | 3.39 Billion DKK | 6.59% |
| 2023 FY | 3.52 Billion DKK | 10.51% |
| 2023 Q3 | 3.55 Billion DKK | 1.28% |
| 2022 Q4 | 3.18 Billion DKK | 5.46% |
| 2022 FY | 3.18 Billion DKK | 31.26% |
| 2022 Q1 | 2.49 Billion DKK | 2.84% |
| 2022 Q2 | 2.87 Billion DKK | 14.94% |
| 2022 Q3 | 3.02 Billion DKK | 5.3% |
| 2021 Q1 | 2.23 Billion DKK | 0.18% |
| 2021 FY | 2.42 Billion DKK | 9.03% |
| 2021 Q4 | 2.42 Billion DKK | 2.1% |
| 2021 Q2 | 2.28 Billion DKK | 2.6% |
| 2021 Q3 | 2.37 Billion DKK | 3.89% |
| 2020 Q1 | 1.91 Billion DKK | -0.83% |
| 2020 Q4 | 2.22 Billion DKK | 5.25% |
| 2020 FY | 2.22 Billion DKK | 15.21% |
| 2020 Q3 | 2.11 Billion DKK | 10.5% |
| 2020 Q2 | 1.91 Billion DKK | -0.1% |
| 2019 Q2 | 1.86 Billion DKK | 2.81% |
| 2019 FY | 1.93 Billion DKK | 12.06% |
| 2019 Q1 | 1.81 Billion DKK | 5.39% |
| 2019 Q3 | 1.91 Billion DKK | 2.41% |
| 2019 Q4 | 1.93 Billion DKK | 0.99% |
| 2018 Q2 | 1.67 Billion DKK | -0.42% |
| 2018 Q3 | 1.67 Billion DKK | 0.0% |
| 2018 FY | 1.72 Billion DKK | 1.95% |
| 2018 Q4 | 1.72 Billion DKK | 2.74% |
| 2018 Q1 | 1.68 Billion DKK | -0.35% |
| 2017 Q1 | 1.62 Billion DKK | 7.11% |
| 2017 FY | 1.69 Billion DKK | 11.46% |
| 2017 Q4 | 1.69 Billion DKK | -2.87% |
| 2017 Q3 | 1.74 Billion DKK | 0.0% |
| 2017 Q2 | 1.74 Billion DKK | 7.13% |
| 2016 Q4 | 1.51 Billion DKK | 1.07% |
| 2016 Q3 | 1.5 Billion DKK | 3.23% |
| 2016 Q2 | 1.45 Billion DKK | -3.32% |
| 2016 FY | 1.51 Billion DKK | 3.05% |
| 2016 Q1 | 1.5 Billion DKK | 2.17% |
| 2015 FY | 1.47 Billion DKK | 11.42% |
| 2015 Q4 | 1.47 Billion DKK | -0.74% |
| 2015 Q3 | 1.48 Billion DKK | 1.16% |
| 2015 Q1 | 1.38 Billion DKK | 4.69% |
| 2015 Q2 | 1.46 Billion DKK | 6.0% |
| 2014 Q3 | 1.21 Billion DKK | 4.73% |
| 2014 Q4 | 1.32 Billion DKK | 8.54% |
| 2014 FY | 1.32 Billion DKK | 23.67% |
| 2014 Q2 | 1.16 Billion DKK | 7.49% |
| 2014 Q1 | 1.08 Billion DKK | 1.22% |
| 2013 Q4 | 1.06 Billion DKK | -1.66% |
| 2013 FY | 1.06 Billion DKK | 6.05% |
| 2013 Q1 | 1.02 Billion DKK | 1.59% |
| 2013 Q3 | 1.08 Billion DKK | 2.55% |
| 2013 Q2 | 1.06 Billion DKK | 3.52% |
| 2012 Q2 | 945 Million DKK | -1.25% |
| 2012 Q1 | 957 Million DKK | 1.16% |
| 2012 Q3 | 962 Million DKK | 1.8% |
| 2012 Q4 | 1 Billion DKK | 4.78% |
| 2012 FY | 1 Billion DKK | 6.55% |
| 2011 Q3 | 1 Billion DKK | -3.1% |
| 2011 Q2 | 1.03 Billion DKK | 4.88% |
| 2011 Q1 | 984 Million DKK | 2.61% |
| 2011 FY | 946 Million DKK | -1.36% |
| 2011 Q4 | 946 Million DKK | -5.4% |
| 2010 FY | 959 Million DKK | -2.74% |
| 2010 Q2 | 981 Million DKK | 7.21% |
| 2010 Q4 | 959 Million DKK | -0.31% |
| 2010 Q3 | 962 Million DKK | -1.94% |
| 2010 Q1 | 915 Million DKK | -7.2% |
| 2009 Q4 | 986 Million DKK | 0.0% |
| 2009 FY | 986 Million DKK | -19.44% |
| 2008 FY | 1.22 Billion DKK | 30.21% |
| 2007 FY | 940 Million DKK | 11.37% |
| 2006 FY | 844 Million DKK | 20.92% |
| 2005 FY | 698 Million DKK | -24.36% |
| 2004 FY | 922.75 Million DKK | 4.5% |
| 2003 FY | 883 Million DKK | 21.29% |
| 2002 FY | 728 Million DKK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -2631616.594% |
| Ansell Limited | 457.04 Million USD | -670.606% |
| Ansell Limited | 457.9 Million USD | -669.164% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -8027.261% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -12628082.144% |
| Psykey, Inc. | 49.94 Thousand USD | -7052362.956% |
| ConvaTec Group Plc | 395.54 Million USD | -790.427% |
| ConvaTec Group Plc | 396.1 Million USD | -789.169% |
| Encision Inc. | 1.4 Million USD | -251052.005% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 37895516.398% |
| LifePoint, Inc. | 2.3 Million USD | -152410.909% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -146466.792% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -798539.456% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -3833077.336% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -362136.486% |
| SmileDirectClub, Inc. | 49.87 Million USD | -6961.796% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -901.282% |
| SheerVision, Inc. | 339.66 Thousand USD | -1036810.114% |
| United Health Products, Inc. | 33.59 Thousand USD | -10482666.831% |
| Vasamed, Inc. | 449.02 Thousand USD | -784260.886% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -41168807.072% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -1093101.479% |